FREE Account Opening + No Clearing Fees
Loading...

Sancode Technologies IPO vs Sotac Pharmaceuticals IPO

Comparision between Sancode Technologies IPO and Sotac Pharmaceuticals IPO.

IPO Details

Sancode Technologies IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
Logo Sancode Technologies IPO Logo Sotac Pharmaceuticals IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At BSE SME NSE SME
Lead Managers Shreni Shares Limited Beeline Capital Advisors Pvt Ltd
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker Shreni Shares Limited Sunflower Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Sancode Technologies IPO is up to ₹5.15 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of Sancode Technologies IPO is ₹47.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹105.00 per share
Issue Price (Upper) ₹111.00 per share
Issue Price (Final) ₹47.00 per share ₹111.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 1200 shares
Fresh Issue Size 10,95,000 shares 30,00,000 shares
Fresh Issue Size (Amount) up to ₹5.15 Cr up to ₹33.30 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 10,95,000 shares 30,00,000 shares
Issue Size Total (Amount) up to ₹5.15 Cr up to ₹33.30 Cr

IPO Timetable

Sancode Technologies IPO opens on Mar 31, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Sancode Technologies IPO and Sotac Pharmaceuticals IPO is Apr 06, 2023, and Apr 03, 2023, respectively.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
Anchor Bid Date Mar 28, 2023
Issue Open Mar 31, 2023 Mar 29, 2023
Issue Close Apr 06, 2023 Apr 03, 2023
Basis Of Allotment (Tentative) Apr 12, 2023 Apr 10, 2023
Initiation of Refunds (Tentative) Apr 13, 2023 Apr 11, 2023
Credit of Share (Tentative) Apr 17, 2023 Apr 12, 2023
Listing date (Tentative) Apr 18, 2023 Apr 13, 2023
Anchor Lockin End date 1 May 12, 2023 May 10, 2023
Anchor Lockin End date 2 Jul 11, 2023 Jul 09, 2023

Financials

Sancode Technologies IPO P/E ratio is 10.71, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
Financial
Sancode Technologies Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-20330.4543.08-112.98220.83197.950.22
31-Mar-21313.96159.74-26.17223.56200.6963.73
31-Mar-22349.87244.8175.12287.07264.1920.76
30-Sep-22481.26180.6289.36367.54344.6721.20
Amount in ₹ Lakhs
Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-203,038.212,882.648.75305.7375.7315.13
31-Mar-213,469.754,894.97-236.54249.3619.361,035.80
31-Mar-223,525.357,337.02287.86662.19432.191,134.59
30-Sep-226,461.603,994.6546.55797.41567.412,185.52
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 97.47% 84.63%
Promoter Shareholding (Post-Issue) 71.24%
P/E Ratio 10.71 132.14
Market Cap ₹19.12 Cr. ₹122.66 Cr.
ROE 6.38%%
ROCE 19.03%%
Debt/Equity 2.74
EPS
RoNW

Shares Offered

In the Sancode Technologies IPO retail investors (RII) are offered 5,19,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 5,19,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Sancode Technologies IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
Anchor Investor Reserveration 8,53,200 shares
Market Maker Reserveration 57,000 shares 1,50,000 shares
QIB 0 shares 5,71,800 shares
NII 5,19,000 shares 4,28,400 shares
RII 5,19,000 shares 9,98,400 shares
Employee 0 shares 0 shares
Others
Total 10,38,000 shares 19,98,600 shares

Bids Received (Subscription)

Sancode Technologies IPO subscribed 3.68x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.

  Sancode Technologies IPO Sotac Pharmaceuticals IPO
QIB (times) 1.00x
NII (times) 3.98x 4.04x
Big NII (times)
Small NII (times)
RII (times) 3.39x 0.91x
Employee (times)
Other (times)
Total (times) 3.68x 1.60x

Comments

Add a public comment...